Bookmark and Share

Iran's first locally-made influenza vaccine to hit market


Source: ISNA

Iran will mass produce the first locally-made influenza vaccine for the first time in 2013, said Iranian Deputy Health Minister for Research and Technology Mostafa Qaneyee. "One of the most important vaccines being produced by Iranian researchers is influenza vaccine y using SPF eggs. The product will hit the market this year," Qaneyee said.

Photo: Pars ampule factory in Saveh, Iran

He further added all phases of building the vaccine are accomplished locally, except SPF eggs. The vaccine will be totally indigenous, if the Iranian researchers can produce the material on their own.

He also said the country has managed to produce vaccines for Rubell and measles indigenously.

According to Qaneyee, Iran is making efforts to produce other types of vaccine including mumps vaccine.

In recent years, Iran has taken wide strides in science and technology, particularly in medical and medicinal fields.

In 2011, Qaneyee who is also Head of Iran's Pasteur Institute had announced that the institute plans to produce human vaccines for rabies and hemophilia diseases.

Pasteur Institute of Iran

He expressed the hope that his institute would start mass-production of the vaccines within the next 2-3 years, adding that the products will be sold not only in domestic, but also in foreign markets.

Also, former Iranian Health Minister Marzieh Vahid Dastjerdi had boasted the country's astonishing progress in producing medical tools, equipment and drugs, saying that Iran ranks first in synthesizing different drugs and medications in the region.

"Iran certainly ranks first in the region in producing medical equipment and medicine and those who stand behind us cannot be compared with Iran at all," Vahid Dastjerdi said, addressing the inaugural ceremony of an international exhibition on medical, dentistry and laboratory equipments in Tehran in 2011.

The former minister further mentioned that Iran exports medical tools and equipment worth $12bln each year and produces 96% of its medical needs, adding that the country also produces 70% of its needed pharmaceutical raw materials domestically.

© Copyright 2013 (All Rights Reserved)